Data from a retrospective analysis have demonstrated a reduction in the probability for patients with type 2 diabetes to develop heart failure when adding exenatide injection to current treatment. The reduction was particularly noted in those patients receiving insulin….

  The dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin exerts an anti-inflammatory effect in patients with type 2 diabetes at the cellular and molecular level.…

Treatment with Liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function.…

In nondiabetic and prediabetic individuals, insulin sensitivity and secretion do not predict spontaneous weight changes; whereas, baseline waist circumference is a positive, independent predictor of weight gain and loss.…

Older type 2’s improve cardiovascular risks when using insulin and targeting postprandial versus fasting glycemia.…

Our publisher, Steve Freed, sat down with Dr. Steven Edelman at the ADA Scientific Sessions in San Diego, and asked, “When should we add the GLP-1 drugs in the progression of diabetes?” and “How comfortable are you with the safety of the GLP-1 drugs?” … Steve Freed:  Thanks for taking …

When making a choice amongst GLP-1 Agonists, the number of injections per day and when peak concentrations are reached are both important in selecting therapy. There was almost unanimous consensus that Exenatide is administered twice daily while Liraglutide is given only one time a day. It was interesting to note …

This week we get back to our interview with Dr. Aaron Vinik, Director, EVMS Strelitz Diabetes Research Center. He has been at the forefront in developing new technologies for growing and regenerating beta cells. Our publisher, Steve Freed, had a few questions for him on how he views the use …

This week, after our publisher Steve Freed was able to connect up with Dr. Vinik again, we bring you more insight on the latest in GLP-1 therapy.  I asked Dr. Vinik , “Who is the ideal type 2 patient for GLP-1 treatment?” and “Can GLP-1 drugs prevent apoptosis and regenerate …

Many times our patients get a Glucagon Kit when they start on insulin and since most patients are taught to only use the injection if they are unconscious, they never use it. However, in this week’s Diabetes Disaster Averted, the use of part of a glucagon injection kit was very …